Introduction/objective <p>Respiratory muscle function may be impaired in axial spondyloarthritis (axSpA) due to mechanical limitations of the thoracic spine and chest wall. However, the extent of respiratory muscle weakness and its clinical associations remain largely underexplored.</p> Methods <p>This comparative cross-sectional study included 51 patients with radiographic axSpA (r-axSpA) and 52 healthy controls. Maximal inspiratory (PI<sub>max</sub>) and expiratory (PE<sub>max</sub>) pressures were measured using standardized protocols. Patients with r-axSpA also underwent assessments of pulmonary functions (forced vital capacity (FVC), forced expiratory volume in the first second (FEV<sub>1</sub>)), spinal pain, disease activity, spinal mobility, functional status, physical performance, quality of life, anxiety/depression, and fatigue. Subgroup analyses were performed based on the presence of respiratory muscle weakness (&lt; 80% of predicted PI<sub>max</sub> and PE<sub>max</sub>), and stepwise multiple regression was used to identify clinical predictors of PI<sub>max</sub>.</p> Results <p>Although the PI<sub>max</sub> (mean difference: − 8.6% [95% CI: − 21.7% to 4.6%]) and PE<sub>max</sub> (mean difference: − 4.6% [95% CI: − 16.7% to 7.5%]) were lower in the r-axSpA group, the differences were not statistically significant (<i>p</i> &gt; 0.05). Seventeen patients (33.3% of the total sample) with r-axSpA exhibited inspiratory muscle weakness. This subgroup demonstrated significantly poorer FVC, spinal pain at rest, spinal mobility, and quality of life (<i>p</i> &lt; 0.05). Regression analysis revealed that pain at rest (<i>β</i> = − 0.317, <i>p</i> = 0.013) and FVC (<i>β</i> = 0.296, <i>p</i> = 0.022) independently predicted 19.2% of the variance in PI<sub>max</sub>.</p> Conclusion <p>Although respiratory muscle strength was mostly preserved in r-axSpA, a substantial subgroup exhibited inspiratory muscle weakness associated with adverse clinical outcomes. Identifying these patients may guide tailored interventions for optimal care.</p> Key Points <p><UnorderedList Mark="Bullet"> <ItemContent> <p>A substantial proportion of patients with radiographic axSpA demonstrate inspiratory muscle weakness despite preserved average respiratory pressures.</p> </ItemContent> <ItemContent> <p>Patients with inspiratory muscle weakness exhibit diminished lung volumes, decreased spinal mobility, higher pain levels, and poorer quality of life compared to those without weakness.</p> </ItemContent> <ItemContent> <p>Inspiratory muscle strength is independently predicted by spinal pain at rest and forced vital capacity.</p> </ItemContent> </UnorderedList></p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Respiratory muscle strength in radiographic axial spondyloarthritis: clinical significance and predictors

  • Devrim Can Sarac,
  • Israfil Inanc,
  • Eren Baskan,
  • Ayten Ozkan,
  • Sercan Gucenmez,
  • Esra Ugur,
  • Dilek Solmaz,
  • Servet Akar,
  • Deniz Bayraktar

摘要

Introduction/objective

Respiratory muscle function may be impaired in axial spondyloarthritis (axSpA) due to mechanical limitations of the thoracic spine and chest wall. However, the extent of respiratory muscle weakness and its clinical associations remain largely underexplored.

Methods

This comparative cross-sectional study included 51 patients with radiographic axSpA (r-axSpA) and 52 healthy controls. Maximal inspiratory (PImax) and expiratory (PEmax) pressures were measured using standardized protocols. Patients with r-axSpA also underwent assessments of pulmonary functions (forced vital capacity (FVC), forced expiratory volume in the first second (FEV1)), spinal pain, disease activity, spinal mobility, functional status, physical performance, quality of life, anxiety/depression, and fatigue. Subgroup analyses were performed based on the presence of respiratory muscle weakness (< 80% of predicted PImax and PEmax), and stepwise multiple regression was used to identify clinical predictors of PImax.

Results

Although the PImax (mean difference: − 8.6% [95% CI: − 21.7% to 4.6%]) and PEmax (mean difference: − 4.6% [95% CI: − 16.7% to 7.5%]) were lower in the r-axSpA group, the differences were not statistically significant (p > 0.05). Seventeen patients (33.3% of the total sample) with r-axSpA exhibited inspiratory muscle weakness. This subgroup demonstrated significantly poorer FVC, spinal pain at rest, spinal mobility, and quality of life (p < 0.05). Regression analysis revealed that pain at rest (β = − 0.317, p = 0.013) and FVC (β = 0.296, p = 0.022) independently predicted 19.2% of the variance in PImax.

Conclusion

Although respiratory muscle strength was mostly preserved in r-axSpA, a substantial subgroup exhibited inspiratory muscle weakness associated with adverse clinical outcomes. Identifying these patients may guide tailored interventions for optimal care.

Key Points

A substantial proportion of patients with radiographic axSpA demonstrate inspiratory muscle weakness despite preserved average respiratory pressures.

Patients with inspiratory muscle weakness exhibit diminished lung volumes, decreased spinal mobility, higher pain levels, and poorer quality of life compared to those without weakness.

Inspiratory muscle strength is independently predicted by spinal pain at rest and forced vital capacity.